| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |